Filing Flows › Comparisons › VSTM vs ADCT
Verastem vs ADC Therapeutics SA: VSTM and ADCT compared
Verastem is the larger company: $24.0M of revenue in its latest quarter (Q3 2026) against $21.7M for ADC Therapeutics SA (Q3 2026). Verastem is growing faster (+114% against +32% a year earlier). ADC Therapeutics SA is more profitable, with an operating margin of -66.1% against -313.3%.
Where the money goes: VSTM and ADCT
Verastem (VSTM) · Q3 2026
Verastem, Q3 2026: revenue $24.0M (+114% year over year), operating margin -313.3%, net loss $74.7M, operating cash flow −$33.6M. The chart follows the revenue to costs, profit and cash.
ADC Therapeutics SA (ADCT) · Q3 2026
ADC Therapeutics SA, Q3 2026: revenue $21.7M (+32% year over year), operating margin -66.1%, net loss $25.3M. The chart follows the revenue to costs, profit and cash.
| Verastem (VSTM) | ADC Therapeutics SA (ADCT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $24.0M | $21.7M |
| Revenue growth, Y/Y | +114% | +32% |
| Operating margin | -313.3% | -66.1% |
| Net earnings | −$74.7M | −$25.3M |
| Net margin | -311.2% | -116.5% |
| Operating cash flow | −$33.6M | — |
| Market value | $848M | — |
| Analysts’ mean target | $17.22 | — |
Where the revenue comes from
ADC Therapeutics SA
- Product revenues, net: $21.0M (97%)
- License revenues and royalties: $710K (3%)
Questions
Which is bigger, Verastem or ADC Therapeutics SA?
Verastem is the larger company: $24.0M of revenue in its latest quarter (Q3 2026) against $21.7M for ADC Therapeutics SA (Q3 2026).
Is Verastem or ADC Therapeutics SA growing faster?
Verastem is growing faster (+114% against +32% a year earlier).
Which is more profitable, Verastem or ADC Therapeutics SA?
ADC Therapeutics SA is more profitable, with an operating margin of -66.1% against -313.3%.
More: Verastem earnings · how Verastem makes money · ADC Therapeutics SA earnings · how ADC Therapeutics SA makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 8-K filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.